REGENXBIO Inc. (RGNX)

REGENXBIO Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	36.55	98.98	347.24	339.76	70.84
Short-Term Investments	240.74	267.69	112.23	137.31	226.7
Cash & Cash Equivalents	277.29	366.67	459.47	477.07	297.54
Cash Growth	-24.38%	-20.20%	-3.69%	60.34%	-7.25%
Receivables	25.49	29.59	34.7	46.27	42.3
Other Current Assets	32.19	19.72	24.66	7.86	5.19
Total Current Assets	334.97	415.98	518.83	531.2	345.03
Property, Plant & Equipment	192.59	206.8	192.45	120.28	39.05
Long-Term Investments	38.87	200.56	391.91	46.81	103.79
Other Long-Term Assets	7.54	9.93	10.72	9.88	10.04
Total Long-Term Assets	239	417.29	595.08	176.97	152.88
Total Assets	573.97	833.27	1,114	708.16	497.91
Accounts Payable	22.79	27.21	11.39	10.62	6.41
Deferred Revenue	0.15	1.83	3.33	4.23	3.33
Current Debt	7.07	6	1.75	2.5	2.42
Other Current Liabilities	100.27	95.4	114	64.09	21.51
Total Current Liabilities	130.27	130.43	130.47	81.45	33.68
Long-Term Debt	82.22	88.8	84.93	70.15	8.87
Other Long-Term Liabilities	49.73	97.84	134.21	178.81	5.16
Total Long-Term Liabilities	131.96	186.64	219.13	248.96	14.04
Total Liabilities	262.23	317.07	349.61	330.41	47.71
Total Debt	89.29	94.8	86.68	72.65	11.3
Debt Growth	-5.81%	9.37%	19.31%	543.23%	92.94%
Retained Earnings	-705.05	-441.55	-161.23	-289.07	-177.82
Comprehensive Income	-4.43	-15.4	-2.57	-0.36	0.21
Shareholders' Equity	311.74	516.2	764.3	377.75	450.2
Net Cash / Debt	188	271.87	372.79	404.42	286.25
Net Cash / Debt Growth	-30.85%	-27.07%	-7.82%	41.28%	-9.12%
Net Cash Per Share	4.30	6.30	8.49	10.85	7.80
Working Capital	204.7	285.54	388.35	449.75	311.36
Book Value Per Share	7.13	11.96	18.01	10.13	12.27

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).